The impact of the time to start radiotherapy (TRT) on overall survival in newly diagnosed glioblastoma.

被引：0
|
作者：
Santos, Vanessa Montes [1 ]
Mesquita, Marcella Coelho [1 ]
Estevez-Diz, Maria Del Pilar [1 ]
Marta, Gustavo N. [1 ]
Feher, Olavo [1 ]
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2040
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Disconnect Between Recurrence-Free Survival and Overall Survival for Newly Diagnosed Glioblastoma Patients Receiving Adjuvant Bevacizumab
    Arvold, N. D.
    Wen, P. Y.
    Reardon, D. A.
    Lee, E. Q.
    Pinnell, N. E.
    Christianson, L. W.
    Weiss, S. E.
    Dunn, I. F.
    Ligon, K. L.
    Alexander, B. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S17 - S17
  • [42] Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Peter G. Zaki
    Sanjeev Herr
    Matthew J. Shepard
    Journal of Neuro-Oncology, 2024, 167 : 363 - 364
  • [43] Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
    Joe S. Mendez
    Ashwin Govindan
    Jacqueline Leong
    Feng Gao
    Jiayi Huang
    Jian L. Campian
    Journal of Neuro-Oncology, 2016, 127 : 329 - 335
  • [44] Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Zaki, Peter G.
    Herr, Sanjeev
    Shepard, Matthew J.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 167 (02) : 363 - 364
  • [45] Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Casucci, Danielle
    Mechtler, Laszlo
    Uhlmann, Erik J.
    Ciesielski, Michael J.
    Fenstermaker, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Temporalis Muscle Width as a Measure of Sarcopenia Independently Predicts Overall Survival in Patients with Newly Diagnosed Glioblastoma
    Hsieh, K.
    Hwang, M.
    Estevez-Inoa, G.
    Saraf, A.
    Spina, C. S.
    Smith, D.
    Wu, C. C.
    Wang, T. J. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E225 - E225
  • [47] Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
    Mendez, Joe S.
    Govindan, Ashwin
    Leong, Jacqueline
    Gao, Feng
    Huang, Jiayi
    Campian, Jian L.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (02) : 329 - 335
  • [48] Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
    Molaie, Donna
    Lai, Albert
    Ellingson, Benjamin M.
    Thien Nguyen
    Bahng, Hye Hyun
    Filka, Emese
    Green, Stacey
    Pope, Whitney B.
    Leng, Mei
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Liz
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Everolimus shortens survival of newly diagnosed glioblastoma patients
    Eric T. Wong
    Kenneth D. Swanson
    Journal of Neuro-Oncology, 2018, 140 : 179 - 180
  • [50] Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4175 - 4180
12345